J. M. Rabey

Rasagiline Mesylate, a New Mao-B Inhibitor for the Treatment of Parkinson's Disease: A Double-Blind Study as Adjunctive Therapy to Levodopa

J. M. Rabey, I Sági, M. Huberman et al. · Clinical Neuropharmacology · 2000 · 177 citations

Translational Medicine, New Mao-b Inhibitor, Adjunctive Therapy +15

Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson's disease

J. M. Rabey, P. Nissipeanu, Amos D. Korczyn · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · 1992 · 136 citations

Medicine, Parkinson Disease, Neuropharmacology +9

The beneficial effect of cholinesterase inhibitors on patients suffering from Parkinson's disease and dementia

Edith Werber, J. M. Rabey · Journal of Neural Transmission · 2001 · 91 citations

Alzheimer's Disease, Medicine, Dementia +13

Improvement of parkinsonian features correlate with high plasma levodopa values after broad bean (Vicia faba) consumption.

J. M. Rabey, Yaffa Vered, H. Shabtai et al. · Journal of Neurology Neurosurgery & Psychiatry · 1992 · 87 citations · Full text

Nutrition, Parkinson Disease, Physiology +12

Clozapine in Parkinson's Disease Psychosis: 5-Year Follow-up Review

Colin Klein, Jacob A. Gordon, Lea Pollak et al. · Clinical Neuropharmacology · 2003 · 86 citations

Neuropsychology, Psychopathology, Psychotropic Medication +18